Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Immuneering Corporation is a late-stage clinical oncology company, with an initial focus on patients with RAS, RAF and other mitogen-activated protein kinase (MAPK)-driven cancers. The Company's lead product candidate, atebimetinib (IMM-1-104), is an investigational, oral, once-daily Deep Cyclic Inhibitor of MEK. The Company is conducting a global randomized pivotal trial, MAPKeeper 301, evaluating atebimetinib in combination with chemotherapy in first-line pancreatic cancer patients. The Company's development pipeline also includes its additional clinical-stage product candidate envometinib (IMM-6-415) and other pre-clinical research programs, including research focused on validated core cancer-signaling pathways outside of the MAPK pathway. The Company's Deep Cyclic Inhibition (DCI) platform is enabled by two key elements: Bioinformatics and 3D Tumor Modeling. Its Deep Cyclic Inhibitors inhibit clinically-validated core signaling pathways, such as the MAPK pathway.
Find out what a historical investment in Immuneering Corp would be worth today using our IMRX stock calculator.
Buying IMRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Immuneering Corp in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in IMRX
What is the ticker symbol of Immuneering Corp?
The ticker symbol for Immuneering Corp is IMRX.
How much is one share of IMRX?
One share of IMRX is valued at $3.45 as of 20 November 2026.
What is the market capitalisation of Immuneering Corp IMRX?
As of 20 November 2026 Immuneering Corp has a market cap of $226.67M.
What is the 52-week high for Immuneering Corp stock?
The Immuneering Corp 52-week high stock price is $8.48.
What is the 52-week low for Immuneering Corp stock?
The Immuneering Corp 52-week low stock price is $3.31.
Can I buy IMRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IMRX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IMRX on Stake
Buy IMRX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of IMRX from only US$10 with fractional shares